fda compounding semaglutide enforcement 2025 news november July 29, 2024: FDA issued new alert about compounded semaglutide – Partnership for Safe Medicines Novo Nordisk expands legal action
Description
Seventy percent of users said they reduced snack consumption, and 45% reported eating less at meals and drinking less alcohol
The FDA issued a February 2026 statement that it "intends to take action against non-FDA-approved GLP-1 drugs." As brand-name supply stabilizes, the legal justification for mass-compounding (which requires a drug shortage) weakens
This spread varies by compound and order size but consistently favors QSC on raw cost per milligram
The dietary strategy should also prioritize adequate protein to support muscle maintenance
